GMN Townhall

Slide Note
Embed
Share

Stay updated with the latest information on Lecanemab and join our patient webinars for additional details on eligibility criteria, side effects, infusion protocols, safety monitoring, and cost.


Uploaded on Dec 22, 2023 | 0 Views


GMN Townhall

PowerPoint presentation about 'GMN Townhall'. This presentation describes the topic on Stay updated with the latest information on Lecanemab and join our patient webinars for additional details on eligibility criteria, side effects, infusion protocols, safety monitoring, and cost.. Download this presentation absolutely free.

Presentation Transcript


  1. GMN Townhall 07.10.2023

  2. ANNOUNCEMENTS Kyle Brunen

  3. Announcements Lecanemab Readiness New MAC Onboarding Providers will receive a link from Reema Parekh for Observership Credentialing (shadowing) GMN PCP Symposium Date: September 22 24, 2023 Location: Jekyll Island Club Resort Approved CMEs available CS Education Webinar: How to communicate to your loved one living with dementia in stressful situations Date: August 8, 2023 Presenter: Betsy Broyles Arnold, CDP, CISM Approved for 1 hour of CE for LMSW, LCSW

  4. LECANEMAB UPDATE Dr. Jim Lah

  5. INFORMATIONAL PATIENT WEBINARS ON LECANEMAB Dr. Chad Hales

  6. Patient Education Webinars In collaboration with the Georgia Memory Net, the Emory Cognitive Clinic is holding a series of zoom webinars to provide patients and families with additional information about eligibility criteria, side effects, infusion protocols, safety monitoring and cost. Dates: Wednesday, July 12, 4pm 5pm Wednesday, July 19, 4pm 5pm Thursday, July 27, 4pm 5pm Note: All webinars will be held on Zoom (https://zoom.us/j/91888063763) No attendee names will be displayed or discussed during the webinar. Attendees will not be able to speak during the webinar, however, there will be an opportunity for submitting questions anonymously at the end of the session. Answers will be discussed during the live session. Information will be shared following the Town Hall.

Related


More Related Content